Lv3
350 积分 2025-01-06 加入
Anti-VEGF safety in evolution: A comprehensive review of ocular and systemic considerations
20天前
已完结
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
1个月前
已完结
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
1个月前
已完结
皖公网安备34019202002308
